Emergent BioSolutions Inc.
EBS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001367644
No open-market purchases or sales by Emergent BioSolutions Inc. insiders were filed in the last 90 days; 194 institutions reported holding it in 13F filings for Q2 2026, worth $373.6M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Emergent BioSolutions Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 140 | 156 | +16 |
| Shares | 31.7M | 34.7M | +3.05M (+9.6%) |
| Value | $264.5M | $332.0M | +$67.5M (+25.5%) |
New holders (37)
Institutions that held Emergent BioSolutions Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (21)
Institutions that held Emergent BioSolutions Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Kent Lake PR LLC | 200,000 | $1.67M |
| SG Americas Securities, LLC | 60,724 | $507.0K |
| Campbell & CO Investment Adviser LLC | 47,717 | $398.4K |
| Quantedge Capital Pte Ltd | 43,800 | $365.7K |
| Whitebox Advisors LLC | 40,427 | $337.6K |
| Graham Capital Management, L.P. | 36,692 | $306.4K |
| Centiva Capital, LP | 31,544 | $263.4K |
| Inceptionr LLC | 30,243 | $252.5K |
| PFG Investments, LLC | 27,253 | $227.6K |
| Engineers Gate Manager LP | 21,789 | $181.9K |
| EntryPoint Capital, LLC | 20,980 | $175.2K |
| Wolverine Trading, LLC | 22,117 | $165.7K |
| Entropy Technologies, LP | 18,600 | $155.3K |
| FORA Capital, LLC | 12,290 | $102.6K |
| Stifel Financial Corp | 11,460 | $95.7K |
| Catalyst Funds Management Pty Ltd | 10,400 | $86.8K |
| Oxford Asset Management LLP | 10,173 | $84.9K |
| nVerses Capital, LLC | 1,500 | $12.5K |
| Financial Freedom, LLC | 300 | $2.50K |
| Nemes Rush Group LLC | 42 | $106 |
| Sawyer & Company, Inc | 15 | $0 |